InsidersTradesSigma
Total declarations
Company
▲ Purchases (13 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
13
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Pridgen William, Director. Insider active across 1 company, notably Virios Therapeutics, Inc.. Aggregated, 13 disclosures have been published. Breakdown: 13 buys · 0 sell. Total volume traded: €253k. Activity tracked since 7 July 2021. The latest transaction was disclosed on 21 August 2023 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations13 total
15,335 shares@ US$1.30377.2% of flowCommon StockSEC:0001415889-23-012474:0
Ideal exit: 17 May 2024 (T+270)
241 shares@ US$4.500.4% of flowCommon StockSEC:0001415889-22-005272:0
Ideal exit: 12 Feb 2023 (T+270)
13,450 shares@ US$4.380223.8% of flowCommon StockSEC:0001415889-22-005214:0
Ideal exit: 11 Feb 2023 (T+270)
600 shares@ US$4.94081.1% of flowCommon StockSEC:0001415889-22-003465:0
Ideal exit: 24 Dec 2022 (T+270)
2,197 shares@ US$5.46274.6% of flowCommon StockSEC:0001415889-22-003314:0
Ideal exit: 18 Dec 2022 (T+270)
4,180 shares@ US$5.98039.5% of flowCommon StockSEC:0001415889-22-000846:0
Ideal exit: 24 Oct 2022 (T+270)
4,180 shares@ US$5.98038.8% of flowCommon StockSEC:0001415889-22-000846
Ideal exit: 24 Oct 2022 (T+270)
2,215 shares@ US$5.43294.2% of flowCommon StockSEC:0001415889-22-000167
Ideal exit: 30 Sept 2022 (T+270)
2,215 shares@ US$5.43294.5% of flowCommon StockSEC:0001415889-22-000167:0
Ideal exit: 30 Sept 2022 (T+270)
8,827 shares@ US$5.664117.5% of flowCommon StockSEC:0001415889-21-006174
Ideal exit: 17 Sept 2022 (T+270)
8,827 shares@ US$5.664118.9% of flowCommon StockSEC:0001415889-21-006174:0
Ideal exit: 17 Sept 2022 (T+270)
942 shares@ US$6.3172.1% of flowCommon StockSEC:0001415889-21-003569:0
Ideal exit: 3 Apr 2022 (T+270)
942 shares@ US$6.3172.0% of flowCommon StockSEC:0001415889-21-003569
Ideal exit: 3 Apr 2022 (T+270)
13 of 13 declarations
About Pridgen William
William Pridgen serves as a Director at Virios Therapeutics, Inc. As a board member, he participates in overseeing operations and strategic decision-making. His experience in the pharmaceutical sector is valuable in guiding Virios' activities. William Pridgen is committed to supporting the company's mission and objectives.
